Suppr超能文献

精神分裂症谱系障碍首次诊断后的死亡率:一项基于人群的回顾性队列研究。

Mortality After the First Diagnosis of Schizophrenia-Spectrum Disorders: A Population-based Retrospective Cohort Study.

机构信息

Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada.

出版信息

Schizophr Bull. 2021 Apr 29;47(3):864-874. doi: 10.1093/schbul/sbaa180.

Abstract

There is emerging evidence of high mortality rates after the first diagnosis of psychotic disorder. The objective of this study was to estimate the standardized mortality ratio (SMR) in a population-based cohort of individuals with a first diagnosis of schizophrenia-spectrum psychotic disorder (SSD). The cohort included a population-based sample of individuals with a first diagnosis of SSD based on the first diagnosis occurring during hospitalization or in an outpatient setting between 2007 and 2010 in Ontario, Canada. All patients were followed for 5 years after the first diagnosis. The primary outcome was SMR, including all-cause, suicide-related, accidental, and other causes. Between 2007 and 2010, there were 2382 patients in the hospitalization cohort and 11 003 patients in the outpatient cohort. Over the 5-year observation period, 97 (4.1%) of the hospitalization cohort and 292 (2.7%) of the outpatient cohort died, resulting in an SMR of 13.6 and 9.1, respectively. In both cohorts, suicide was the most common cause of death. Approximately 1 in 25 patients with a first diagnosis of SSD during hospitalization, and 1 in 40 patients with a first diagnosis of SSD in an outpatient setting, died within 5 years of first diagnosis in Ontario, Canada. This mortality rate is between 9 and 13 times higher than would be expected in the age-matched general population. Based on these data, timely access to services should be a public health priority to reduce mortality following a first diagnosis of an SSD.

摘要

在首次诊断出精神病障碍后,死亡率不断上升。本研究旨在评估基于人群的首次诊断为精神分裂症谱系精神病障碍(SSD)患者队列的标准化死亡率(SMR)。该队列包括加拿大安大略省 2007 年至 2010 年期间首次住院或门诊诊断为 SSD 的人群。所有患者在首次诊断后的 5 年内均接受随访。主要结局指标为 SMR,包括全因、自杀相关、意外和其他原因。2007 年至 2010 年,住院组有 2382 例患者,门诊组有 11003 例患者。在 5 年观察期内,住院组有 97 例(4.1%),门诊组有 292 例(2.7%)死亡,SMR 分别为 13.6 和 9.1。在这两个队列中,自杀是最常见的死亡原因。在加拿大安大略省,首次住院诊断为 SSD 的患者中,约每 25 例患者中有 1 例,首次门诊诊断为 SSD 的患者中,每 40 例患者中有 1 例,在首次诊断后 5 年内死亡。这一死亡率是年龄匹配的一般人群的 9 到 13 倍。基于这些数据,及时获得服务应该是公共卫生的优先事项,以降低首次诊断为 SSD 后的死亡率。

相似文献

引用本文的文献

本文引用的文献

10
Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative.美国精神分裂症治疗模式的转变:RAISE 倡议。
Annu Rev Clin Psychol. 2018 May 7;14:237-258. doi: 10.1146/annurev-clinpsy-050817-084934. Epub 2018 Jan 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验